Funding This review was supported by Beijing Municipal Science &Technology Commission, Beijing Municipal Natural Science Foundation, No
Vacca, A., Ribatti, D., Iurlaro, M., Merchionne, F., Nico, B., Ria, R., et al
DuMont AL, Cianciotto NP
Antibodies specific for ACTL6A (Abcam, ab3882, 1:4000), GCLC (Abcam, ab190685, 1:4000), anti-NRF2 (Cell Signaling Technology, 12721 s, 1:2000), flag-tag (Sigma, F1804, 1:5000), and GAPDH (Proteintech, 10494-1-AP, 1:5000) were purchased from the indicated companies
315 The results showed that, in the OA rat model, liraglutide could activate the PKA/CREB signaling pathway and inhibit the inflammatory response through this pathway, thereby alleviating OA symptoms